Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

The following tables provide detail by sales category:


	2024						2023						2022
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	3,858	$	3,858	$	—	$	3,807	$	3,807	$	—	$	3,766	$	3,766
Other	—		1,336		1,336		—		1,259		1,259		—		1,146		1,146
Total	—		5,194		5,194		—		5,066		5,066		—		4,912		4,912

Nutritional Products —
Pediatric Nutritionals	2,208		1,815		4,023		1,977		1,957		3,934		1,562		1,919		3,481
Adult Nutritionals	1,481		2,909		4,390		1,436		2,784		4,220		1,357		2,621		3,978
Total	3,689		4,724		8,413		3,413		4,741		8,154		2,919		4,540		7,459

Diagnostic Products —
Core Laboratory	1,332		3,903		5,235		1,243		3,916		5,159		1,137		3,751		4,888
Molecular	150		371		521		172		402		574		370		625		995
Point of Care	408		180		588		396		169		565		372		153		525
Rapid Diagnostics	1,940		1,057		2,997		2,518		1,172		3,690		6,652		3,409		10,061
Total	3,830		5,511		9,341		4,329		5,659		9,988		8,531		7,938		16,469

Medical Devices —
Rhythm Management	1,154		1,236		2,390		1,085		1,170		2,255		1,029		1,090		2,119
Electrophysiology	1,141		1,326		2,467		1,008		1,187		2,195		909		1,018		1,927
Heart Failure	986		293		1,279		888		273		1,161		809		226		1,035
Vascular	1,056		1,781		2,837		978		1,703		2,681		864		1,619		2,483
Structural Heart	1,051		1,195		2,246		883		1,061		1,944		818		894		1,712
Neuromodulation	767		195		962		725		165		890		619		151		770
Diabetes Care	2,633		4,172		6,805		2,129		3,632		5,761		1,633		3,123		4,756
Total	8,788		10,198		18,986		7,696		9,191		16,887		6,681		8,121		14,802

Other	16		—		16		14		—		14		11		—		11

Total	$	16,323	$	25,627	$	41,950	$	15,452	$	24,657	$	40,109	$	18,142	$	25,511	$	43,653

Note: The Acelis Connected Health business was internally transferred from Rapid Diagnostics to Heart Failure on January 1, 2023. As a result, $115 million of sales in 2022 were moved from Rapid Diagnostics to Heart Failure.

Schedule of Changes in Contract Liabilities

Changes in the contract liabilities during the period are as follows:


(in millions)
Contract Liabilities:
Balance at December 31, 2022	$	500
Unearned revenue from cash received during the period	469
Revenue recognized related to contract liability balance	(424)
Balance at December 31, 2023	545
Unearned revenue from cash received during the period	483
Revenue recognized related to contract liability balance	(460)
Balance at December 31, 2024	$	568